youtube_live
Q3 2026 earnings • in 4 days
See detailschevron_right
RGA:NYSE
Reinsurance Group of America Inc
$267.41
arrow_upward
+1.01%(+2.68) 1D
$267.41
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 2, 4:00:02 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RGA...
Open
$266.00
High
$269.12
Low
$263.75
Mkt. cap
17.46B
Avg. vol.
427.92K
Volume
503.54K
Dividend
1.47%
Quarterly dividend
$0.98
Ex-dividend date
Aug 18, 2026
P/E ratio
11.73
52-wk high
$272.44
52-wk low
$179.52
EPS
$22.80
Beta
0.45
Shares outstanding
65.30M
No. of employees
4K
Open
$266.00
High
$269.12
Low
$263.75
Mkt. cap
17.46B
Avg. vol.
427.92K
Volume
503.54K
Dividend
1.47%
Quarterly dividend
$0.98
Ex-dividend date
Aug 18, 2026
P/E ratio
11.73
52-wk high
$272.44
52-wk low
$179.52
EPS
$22.80
Beta
0.45
Shares outstanding
65.30M
No. of employees
4K
News stories
From web sources and news partners
Yahoo Finance
·
6 hours ago
Will Reinsurance Group (RGA) Beat Estimates Again in Its Next Earnings Report?
Yahoo Finance
·
3 days ago
Should Value Investors Buy Reinsurance Group of America (RGA) Stock?
Profile
Reinsurance Group of America, Incorporated is a holding company for a global life and health reinsurance entity based in Greater St. Louis within the western suburb of Chesterfield, Missouri, United States. With approximately $4.3 trillion of life reinsurance in force and total assets of $156.6 billion as of December 31, 2025, RGA has grown to become the only international company to focus primarily on life and health-related reinsurance. Wikipedia
About Reinsurance Group of America Inc
CEOTony Cheng
Employees4.3K
Founded1973
HeadquartersChesterfield, Missouri, United States
SectorInsurance
Websitergare.com
Analyst ratings
Based on 7 analysts giving stock ratings to RGA in the past 3 months
Buy
Buy
5
Hold
1
Sell
1
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for RGA in the last 3 months.
Highest
Current $267.41
$297.00 (+11.07%)
Average
$283.33 (+5.95%)
Lowest
$250.00 (-6.51%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Andrew Kligerman TD Cowen | Hold | Maintained | $250.00 | -6.5% | 10/21/2026 |
Pablo Singzon J.P. Morgan | Buy | Maintained | $297.00 | +11.1% | 10/15/2026 |
Wesley Carmichael Wells Fargo | Buy | Maintained | $292.00 | +9.2% | 10/12/2026 |
Paul Newsome Piper Sandler | Buy | Maintained | $274.00 | +2.5% | 10/12/2026 |
Alex Scott Barclays | Buy | Maintained | $292.00 | +9.2% | 10/07/2026 |
Bob Huang Morgan Stanley | Buy | Reiterated | $295.00 | +10.3% | 10/05/2026 |
Wilma Burdis Raymond James | Sell | Maintained | - | - | 08/27/2026 |
Elyse Greenspan Wells Fargo | Buy | Maintained | $291.00 | +8.8% | 08/19/2026 |
Suneet Kamath Jefferies | Buy | Maintained | $288.00 | +7.7% | 07/09/2026 |
Michael Ward CFA UBS | Hold | Reiterated | $236.00 | -11.7% | 07/08/2026 |
Thomas Gallagher Evercore ISI | Buy | Maintained | $267.00 | -0.2% | 05/18/2026 |
John Barnidge Piper Sandler | Buy | Reiterated | $261.00 | -2.4% | 05/11/2026 |
Jimmy Bhullar J.P. Morgan | Buy | Maintained | $270.00 | +1% | 05/07/2026 |
Next call in 4 days
Fri, Nov 6, 5:00 PM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $6.95
Revenue / Est. (USD)
- / 6.67B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 6.20B | 6.64B | 6.49B | 6.64B |
Cost of goods sold | 5.46B | 5.65B | 5.63B | 5.58B |
Cost of revenue | 5.46B | 5.65B | 5.63B | 5.58B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | - | - | - | - |
Operating expense | 328.00M | 380.00M | 326.00M | 348.00M |
Total operating expenses | 5.79B | 6.03B | 5.95B | 5.93B |
Operating income | 418.00M | 608.00M | 540.00M | 706.00M |
Other non operating income | - | - | - | - |
EBT including unusual items | 320.00M | 510.00M | 441.00M | 605.00M |
EBT excluding unusual items | 320.00M | 510.00M | 441.00M | 605.00M |
Income tax expense | 65.00M | 45.00M | 110.00M | 141.00M |
Effective tax rate | 20.31% | 8.82% | 24.94% | 23.31% |
Other operating expenses | 328.00M | 338.00M | 326.00M | 348.00M |
Net income | 253.00M | 463.00M | 330.00M | 462.00M |
Net profit margin | 4.08% | 6.98% | 5.08% | 6.96% |
Earnings per share | 4.66 | 7.75 | 6.97 | 8.89 |
Interest and investment income | - | - | - | - |
Interest expense | -98.00M | -98.00M | -99.00M | -101.00M |
Net interest expenses | -98.00M | -98.00M | -99.00M | -101.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 429.50M | 618.75M | 550.75M | 716.75M |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events